BACKGROUND: Regional prefrontal cortex gray matter reductions have been identified in schizophrenia, likely reflecting a combination of genetic vulnerability and disease effects. Few morphometric studies to date have examined regional prefrontal abnormalities in non-psychotic biological relatives who have not passed through the age range of peak risk for onset of psychosis. We conducted a region-of-interest morphometric study of prefrontal subregions in adolescent and young adult relatives of schizophrenia patients. METHODS: Twenty-seven familial high-risk (FHR) first-degree relatives of schizophrenia patients and forty-eight control subjects without a family history of psychosis (ages 13-28) underwent high-resolution magnetic resonance imaging at 1.5Tesla. The prefrontal cortex was parcellated into polar, dorsolateral, ventrolateral, ventromedial and orbital subregions. The Chapman scales measured subpsychotic symptoms. General linear models examined associations of prefrontal subregion volumes with familial risk and subpsychotic symptoms. RESULTS: FHR subjects had significantly reduced bilateral ventromedial prefrontal and frontal pole gray matter volumes compared with controls. Ventromedial volume was significantly negatively correlated with magical ideation and anhedonia scores in FHR subjects. CONCLUSIONS: Selective, regional prefrontal gray matter reductions may differentially mark genetic vulnerability and early symptom processes among non-psychotic young adults at familial risk for schizophrenia.
BACKGROUND: Regional prefrontal cortex gray matter reductions have been identified in schizophrenia, likely reflecting a combination of genetic vulnerability and disease effects. Few morphometric studies to date have examined regional prefrontal abnormalities in non-psychotic biological relatives who have not passed through the age range of peak risk for onset of psychosis. We conducted a region-of-interest morphometric study of prefrontal subregions in adolescent and young adult relatives of schizophreniapatients. METHODS: Twenty-seven familial high-risk (FHR) first-degree relatives of schizophreniapatients and forty-eight control subjects without a family history of psychosis (ages 13-28) underwent high-resolution magnetic resonance imaging at 1.5Tesla. The prefrontal cortex was parcellated into polar, dorsolateral, ventrolateral, ventromedial and orbital subregions. The Chapman scales measured subpsychotic symptoms. General linear models examined associations of prefrontal subregion volumes with familial risk and subpsychotic symptoms. RESULTS: FHR subjects had significantly reduced bilateral ventromedial prefrontal and frontal pole gray matter volumes compared with controls. Ventromedial volume was significantly negatively correlated with magical ideation and anhedonia scores in FHR subjects. CONCLUSIONS: Selective, regional prefrontal gray matter reductions may differentially mark genetic vulnerability and early symptom processes among non-psychotic young adults at familial risk for schizophrenia.
Authors: Larry J Seidman; Heidi W Thermenos; Russell A Poldrack; Nicole K Peace; Jennifer K Koch; Stephen V Faraone; Ming T Tsuang Journal: Schizophr Res Date: 2006-04-24 Impact factor: 4.939
Authors: Nicole R Giuliani; Vince D Calhoun; Godfrey D Pearlson; Alan Francis; Robert W Buchanan Journal: Schizophr Res Date: 2005-05-01 Impact factor: 4.939
Authors: Vaibhav A Diwadkar; Debra M Montrose; Diana Dworakowski; John A Sweeney; Matcheri S Keshavan Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2005-11-28 Impact factor: 5.067
Authors: Hilleke E Hulshoff Pol; Hugo G Schnack; René C W Mandl; Rachel G H Brans; Neeltje E M van Haren; Wim F C Baaré; Clarine J van Oel; D Louis Collins; Alan C Evans; René S Kahn Journal: Neuroimage Date: 2006-02-23 Impact factor: 6.556
Authors: Andrew M McIntosh; Dominic E Job; William J Moorhead; Lesley K Harrison; Heather C Whalley; Eve C Johnstone; Stephen M Lawrie Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2006-01-05 Impact factor: 3.568
Authors: Daqiang Sun; Lisa Phillips; Dennis Velakoulis; Alison Yung; Patrick D McGorry; Stephen J Wood; Theo G M van Erp; Paul M Thompson; Arthur W Toga; Tyrone D Cannon; Christos Pantelis Journal: Schizophr Res Date: 2009-01-12 Impact factor: 4.939
Authors: William P Horan; Steven P Reise; Kenneth L Subotnik; Joseph Ventura; Keith H Nuechterlein Journal: Schizophr Res Date: 2008-01-24 Impact factor: 4.939
Authors: Yaling Yang; Keith H Nuechterlein; Owen R Phillips; Boris Gutman; Florian Kurth; Ivo Dinov; Paul M Thompson; Robert F Asarnow; Arthur W Toga; Katherine L Narr Journal: Hum Brain Mapp Date: 2012-09 Impact factor: 5.038
Authors: Marco M Picchioni; Fruhling Rijsdijk; Timothea Toulopoulou; Christopher Chaddock; James H Cole; Ulrich Ettinger; Ana Oses; Hugo Metcalfe; Robin M Murray; Philip McGuire Journal: J Psychiatry Neurosci Date: 2017-03 Impact factor: 6.186
Authors: Benjamin K Brent; Isabelle M Rosso; Heidi W Thermenos; Daphne J Holt; Stephen V Faraone; Nikos Makris; Ming T Tsuang; Larry J Seidman Journal: Schizophr Res Date: 2015-11-24 Impact factor: 4.939
Authors: Alan N Francis; Larry J Seidman; Gul A Jabbar; Raquelle Mesholam-Gately; Heidi W Thermenos; Richard Juelich; Ashley C Proal; Martha Shenton; Marek Kubicki; Ian Mathew; Matcheri Keshavan; Lynn E Delisi Journal: Schizophr Res Date: 2012-08-11 Impact factor: 4.939